metricas
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
ISSN: 2253-8089

The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging.
The Journal, which publishes six regular issues per year, is committed to fostering research and advancing continuing education across all domains of Nuclear Medicine. Its main sections include Original Articles, Images of Interest, and Special Collaboration papers. Manuscripts may be submitted in either Spanish or English and are subject to a rigorous peer-review process prior to publication.

See more Open Access Option
Indexed in:

Medline

See more
Follow us
Contact
Subscribe
Alert
Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more
Impact factor 2025
1.2
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2024
0.9
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2024
0.216
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2024
0.216
View more metrics
Hide
Issue
Cover Vol. 45. Issue 5. Vol. 45. Issue 5.
(September - October 2026)
Editorial
The Spanish Society of Nuclear Medicine and Molecular Imaging’s position on preparing the health system for new Alzheimer’s disease treatments
Junta Directiva de la Sociedad Española de Medicina Nuclear e Imagen Molecular
Rev Esp Med Nucl Imagen Mol. 2026;45:
Original articles
Optimization of axillary staging in breast cancer: Efficacy of sentinel lymph node biopsy and targeted axillary dissection post-chemotherapy
A. García-Ruiz, I. Martínez-Rodríguez, N. Martínez-Amador, F.J. Gómez-de la Fuente, A. Sánchez-Salmón, J. Jiménez-Bonilla, M. de Arcocha-Torres, V. Mendi Barcina, ... R. Quirce
Rev Esp Med Nucl Imagen Mol. 2026;45:
Impact of [18F]F-choline PET/CT on the management of high-risk prostate cancer
C. Cases-Pellisé, J.L. Villa Palacios, R.M. Álvarez-Pérez, E.M. Triviño-Ibáñez, L. Brero Sánchez, V. Pachón Garrudo, I. Cejudo Liébana, R. Sánchez Sánchez, ... A. Rodríguez-Fernández
Rev Esp Med Nucl Imagen Mol. 2026;45:
Full text access
Open Article
Therapeutic impact of 18F-PSMA-1007 PET/MRI in staging intermediate/high-risk prostate cancer patients: Imaging biomarkers and radiomic analysis associated with tumor aggressiveness
J.R. Garcia, L. Pinilla, A. Compte, N. Garrido, L.L. Mont-Castro, S. Ruiz, J. Garcia Magro, J.M. Santabárbara, ... E. Riera
Rev Esp Med Nucl Imagen Mol. 2026;45:
Interesting images
Bilateral lacrimal gland MALT lymphoma incidentally detected on 68Ga-DOTATATE PET/CT: an unusual but noticeable finding
C. Kucuker, S. Akin, D.P. Baran, E. Gumeler, A. Uner, P. Kiratli
Rev Esp Med Nucl Imagen Mol. 2026;45:
A rare case of synchronous multicentric paragangliomas detected using [⁶⁸Ga]Ga-DOTATATE PET/CT
N. Aydinbelge Dizdar, A. Dursun, M. Samsum, O. Ozmen
Rev Esp Med Nucl Imagen Mol. 2026;45:
Reversible cortical hypometabolism in prolonged migraine aura: findings on 18[F]FDG PET/CT
Diego Alfonso López-Mora, Lucia Lozano Murgas, Antoni Mestre-Fusco, Maria Isabel Santisteban Gutierrez, Ato Antonio Rodriguez Revuelto
Rev Esp Med Nucl Imagen Mol. 2026;45:
Continuing education
PSMA-PET as an emerging tool for response assessment in metastatic prostate cancer (mPC): Revolution and necessary evolution
N. Álvarez Mena, J. Gómez Hidalgo, M.P. Fierro Alanis, P. García-Talavera San Miguel, A. Roteta Unceta Barrenechea, S. Menéndez Sánchez, J.E. Montalvá Pastor, J.A. Badell Martínez, ... en nombre del Grupo de Oncología de la SEMNIM
Rev Esp Med Nucl Imagen Mol. 2026;45:
Letters to the editors
asdasdasd